Skip to main content

Definition, Diagnosis, Epidemiology, Etiology and Pathophysiology of Heart Failure

  • Chapter
  • First Online:
  • 2254 Accesses

Abstract

Heart failure (HF) is the culmination of all preceding cardiovascular events and the successes and failures of attempted and administered interventions. It is the cumulative effects of all abnormalities in the heart, which culminate in the functional impairment of the cardiac pump. Once the patient reaches the stage of symptomatic HF, the prognosis becomes poor. The more severe the HF, the nearer the patient is to death, and therefore the less room for mistakes in managing these patients. For these reasons, attention to details such as accuracy of diagnoses, correct assessments of severity, profound understanding of the pathophysiological processes and institution of timely therapy are crucial, and it calls for no less than the most skilled of HF specialists if the patients were to stand any chance of successfully fighting against this lethal condition. This chapter intends to lay the foundations for rational approaches to therapy.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology; Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388-2442.

    Google Scholar 

  2. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Curr Opin Cardiol. 2003;18:215-222.

    Article  PubMed  Google Scholar 

  3. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J. 1991;121(3 pt 1):951-957.

    Article  PubMed  CAS  Google Scholar 

  4. http://www.heartstats.org. Accessed 21 Jan 2009.

  5. Cowie MR, Wood DA, Coats AJS, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20:421-428.

    Article  PubMed  CAS  Google Scholar 

  6. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail. 2002;4(3):361-371.

    Article  PubMed  Google Scholar 

  7. Cowie MR, Wood DA, Coats AJ, et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20(6):421-428.

    Article  PubMed  CAS  Google Scholar 

  8. Bart BA, Shaw LK, McCants CB Jr, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 1997;30:1002-1008.

    Article  PubMed  CAS  Google Scholar 

  9. Williams SG, Tzeng B-H, Tan LB. Cardiogenic shock: physiological and biochemical concepts. In: David Hasdai, Peter B Berger, Alexander Battler, David R Holmes Jr, eds. Cardiogenic Shock: Diagnosis and Treatment. New Jersey: Humana; 2002:7-32.

    Google Scholar 

  10. Williams SG, Wright DJ, Tan LB. Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice. Heart. 2000;83:621-626.

    Article  PubMed  CAS  Google Scholar 

  11. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med. 1972;287:781-787.

    Article  PubMed  CAS  Google Scholar 

  12. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.

    Article  PubMed  CAS  Google Scholar 

  13. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077-1084.

    Article  PubMed  CAS  Google Scholar 

  14. Williams SG, Barker D, Goldspink DF, Tan LB. A reappraisal of concepts in heart failure: Central role of cardiac power reserve. Arch Med Sci. 2005;1:65-74.

    Google Scholar 

  15. Harris P. Evolution and the cardiac patient. Cardiovasc Res. 1983;17(7):437-445.

    Article  PubMed  CAS  Google Scholar 

  16. Lang CC, Mancini DM. Non-cardiac comorbidities in chronic heart failure. Heart. 2007;93:665-671.

    Article  PubMed  Google Scholar 

  17. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997;45:968-974.

    PubMed  CAS  Google Scholar 

  18. Wei JY. Age and the cardiovascular system. N Engl J Med. 1992;327:1735-1739.

    Article  PubMed  CAS  Google Scholar 

  19. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev. 1993;73:413-467.

    PubMed  CAS  Google Scholar 

  20. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res. 1991;68:1560-1568.

    Google Scholar 

  21. Fleg JL, O’Connor F, Gerstenblith G, et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol. 1995;78:890-900.

    PubMed  CAS  Google Scholar 

  22. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42:1226-1233.

    Article  PubMed  Google Scholar 

  23. Tan LB, Murphy R. Shifts in mortality curves: saving or extending lives? Lancet. 1999;354:1378-1381.

    Article  PubMed  CAS  Google Scholar 

  24. Rich MW. Heart failure in the oldest patients: the impact of comorbid conditions. Am J Geriatr Cardiol. 2005;14:134-141.

    Article  PubMed  Google Scholar 

  25. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-1786.

    Article  PubMed  Google Scholar 

  26. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035-2038.

    Article  PubMed  CAS  Google Scholar 

  27. Rodrigues B, McNeill JH. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res. 1992;26:913-922.

    Article  PubMed  CAS  Google Scholar 

  28. Williams SG, Ng LL, O’Brien R, Taylor S, Wright DJ, Tan LB. Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study. Eur J Heart Fail. 2004;6(7):891-900.

    PubMed  CAS  Google Scholar 

  29. Latini R, Masson S, Wong M, et al. for the Val-HeFT Investigators. Incremental prognostic value of changes in B-type natriuretic peptide in heart failure with depressed ejection fraction. Am J Med. 2006;119:70.e23-70.e30.

    Google Scholar 

  30. Urban P, Stauffer JC, Bleed D, et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J. 1999;20:1030-1038.

    Article  PubMed  CAS  Google Scholar 

  31. Fincke R, Hochman JS, Lowe AM, et al.; SHOCK Investigators. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2004;44(2):340-348.

    Google Scholar 

  32. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42:1226-1233.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lip-Bun Tan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer London

About this chapter

Cite this chapter

Tan, LB., Lewis, N., Barker, D. (2010). Definition, Diagnosis, Epidemiology, Etiology and Pathophysiology of Heart Failure. In: Henein, M. (eds) Heart Failure in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84996-153-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-153-0_1

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-152-3

  • Online ISBN: 978-1-84996-153-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics